Ignoring these can lead to inflammation, fatty liver disease, or even liver failure over time. Read on factors that can ...

At least four percent children under two years of age have received no vaccines. Experts stress targeted plans to close the ...

Mails Letter to Stockholders Urging Stockholders to Vote FOR All Four Dynavax Director Nominees on the GOLD Proxy Card ...

Within the Cherokee Nation, there are likely thousands of people homeless, a living condition linked to reduced life ...

Story April 1 - Sail Biomedicines: Flagship Pioneering-backed Sail has laid off 12 employees following a review of the company’s organizational structure, leaving 125 staff still employed at the ...

Q1 2025 Earnings Conference Call April 30, 2025 7:00 AM ETCompany ParticipantsConstantin Fest - Head of IREmma Walmsley - CEOLuke Miels ...

There's a vaccine for hepatitis B that, according to the CDC, can help to prevent millions of deaths worldwide.

Dynavax is kicking off May’s Hepatitis Awareness Month with a new push to improve education around hepatitis B and the ...

A pioneering study uncovers crucial immune dynamics in hepatitis B, offering new insights into how immune responses evolve ...

PBGENE-HBV is designed to potentially cure chronic hepatitis B by eliminating the root cause of the virus. The Food and Drug Administration (FDA) has granted Fast Track designation to PBGENE-HBV, an ...

Functional cure of chronic hepatitis B (CHB) remains a major clinical challenge. Current therapies—including nucleos(t)ide ...

Hepatitis A and B are the most common vaccine-preventable diseases for travelers; nevertheless, up to 50% of confirmed cases of hepatitis A and B in Europe are still acquired during travel.